切换至 "中华医学电子期刊资源库"

中华普通外科学文献(电子版) ›› 2020, Vol. 14 ›› Issue (03) : 211 -213. doi: 10.3877/cma.j.issn.1674-0793.2020.03.011

所属专题: 专题评论 文献

论著

肠型脂肪酸结合蛋白应用于重症急性胰腺炎胃肠道功能及病情评估的研究
王龙辉1,(), 刘群亮1, 周云鹏1, 孙国志1, 杨妮1, 王猛1   
  1. 1. 266100 青岛市第八人民医院普外一科
  • 收稿日期:2019-08-26 出版日期:2020-06-01
  • 通信作者: 王龙辉
  • 基金资助:
    青岛市医药科研指导计划资助项目(2017-WJZD084)

Application of intestinal fatty acid binding protein in the evaluation of gastrointestinal function and condition in severe acute pancreatitis

Longhui Wang1,(), Qunliang Liu1, Yunpeng Zhou1, Guozhi Sun1, Ni Yang1, Meng Wang1   

  1. 1. Department of General Surgery, Qingdao Eighth People’s Hospital, Qingdao 266100, China
  • Received:2019-08-26 Published:2020-06-01
  • Corresponding author: Longhui Wang
  • About author:
    Corresponding author: Wang Longhui, Email:
引用本文:

王龙辉, 刘群亮, 周云鹏, 孙国志, 杨妮, 王猛. 肠型脂肪酸结合蛋白应用于重症急性胰腺炎胃肠道功能及病情评估的研究[J]. 中华普通外科学文献(电子版), 2020, 14(03): 211-213.

Longhui Wang, Qunliang Liu, Yunpeng Zhou, Guozhi Sun, Ni Yang, Meng Wang. Application of intestinal fatty acid binding protein in the evaluation of gastrointestinal function and condition in severe acute pancreatitis[J]. Chinese Archives of General Surgery(Electronic Edition), 2020, 14(03): 211-213.

目的

探讨肠型脂肪酸结合蛋白(I-FABP)在重症急性胰腺炎(SAP)患者胃肠道功能障碍严重程度以及病情评估中的意义。

方法

选取2016年12月至2018年12月青岛市第八人民医院收治的34例SAP患者,收集入院时患者血清I-FABP、降钙素原(PCT)、C反应蛋白(CRP)浓度以及白细胞计数等临床资料,并进行胃肠功能障碍程度评分以及急性生理与慢性健康状况(APACHEⅡ)评分,将以上指标与I-FABP质量浓度进行相关性分析。

结果

入院时I-FABP浓度为(551±204)ng/L,PCT浓度为(3.36±1.79)μg/L,CRP浓度为(171±73)mg/L,白细胞计数为(14.47±4.09)×109/L,APACHE Ⅱ评分为(12±5)分,胃肠道功能障碍评分为(10±2)分。患者血清I-FABP浓度和入院时PCT、CRP浓度、白细胞计数、APACHEⅡ评分、胃肠道功能评分均呈正相关关系(P<0.01),r分别为0.537、0.662、0.730、0.716、0.686。

结论

血清I-FABP与血清炎性指标、APACHEⅡ评分和胃肠道功能评分存在相关性,有助于评估SAP患者的胃肠功能障碍及疾病严重程度。

Objective

To study the significance of intestinal fatty acid binding protein (I-FABP) in the severity of gastrointestinal dysfunction and the assessment of disease severity in severe acute pancreatitis (SAP) patients.

Methods

From December 2016 to December 2018, thirty-four patients with SAP admitted to Qingdao Eighth Peoples Hospital were selected. Levels of serum I-FABP, procalcitonin (PCT), C-reactive protein (CRP) and white blood cell count were collected at admission. The patients were scored for gastrointestinal dysfunction and Acute Physiological and Chronic Health Status Score Ⅱ (APACHEⅡ). The correlations between serum I-FABP level and the above markers were analyzed.

Results

The concentration of I-FABP at admission was (551±204) ng/L, the PCT concentration was (3.36±1.79) μg/L, the CRP concentration was (171±73) mg/L, and the white blood cell count was (14.47±4.09)×109/L, APACHE score was (12±5), and gastrointestinal function score was (10±2). There was positive correlation among the serum I-FABP concentration and the concentration of PCT, CRP, white blood cell count, APACHEⅡ score, and gastrointestinal function score (P<0.01), and r was 0.537, 0.662, 0.730, 0.716, and 0.686 respectively.

Conclusion

Serum I-FABP is correlated with serum inflammatory markers, APACHE Ⅱ and gastrointestinal function score, which is helpful to evaluating gastrointestinal dysfunction and severity of SAP.

图1 血清肠型脂肪酸结合蛋白(I-FABP)浓度与不同指标的Pearson相关分析散点图 A为I-FABP浓度与降钙素原(PCT)浓度;B为I-FABP浓度与患者APACHEⅡ评分;C为血清I-FABP浓度与患者胃肠道功能障碍评分;D为血清I-FABP浓度与C反应蛋白(CRP)浓度;E为血清I-FABP浓度与白细胞计数
[1]
Rahman SH, Ammori BJ, Holmfield J, et al. Intestinal hypoperfusion contributes to gut barrier failure in severe acute pancreatitis[J]. J Gastrointest Surg, 2003, 7(1): 26-36.
[2]
Crockett SD, Wani S, Gardner TB, et al. American Gastroen-terological Association Institute Guideline on initial management of acute pancreatitis[J]. Gastroenterology, 2018, 154(4): 1096-1101.
[3]
Yang L, Liu J, Xing Y, et al. Comparison of BISAP, Ranson, MCTSI, and APACHE in predicting severity and prognoses of hyperlipidemic acute pancreatitis in Chinese patients[J]. Gastroenterol Res Pract, 2016, 2016: 1834256.
[4]
Voth M, Duchene M, Auner B, et al. I-FABP is a novel marker for the detection of intestinal injury in severely injured trauma patients[J]. World J Surg, 2017, 41(12): 3120-3127.
[5]
Lau E, Marques C, Pestana D, et al. The role of I-FABP as a biomarker of intestinal barrier dysfunction driven by gut microbiota changes in obesity[J]. Nutr Metab (Lond), 2016, 13: 31.
[6]
中华医学会消化病学分会胰腺疾病学组, 中华胰腺病杂志编辑委员会, 中华消化杂志编辑委员会. 中国急性胰腺炎诊治指南(2013年,上海)[J]. 中华消化杂志, 2013, 33(4): 217-222.
[7]
Reintam A, Parm P, Kitus R, et al. Gastrointestinal failure score in critically ill patients: A prospective observational study[J]. Crit Care, 2008, 12(4): R90.
[8]
Kupčinskas J, Gedgaudas R, Hartman H, et al. Intestinal fatty acid binding protein as a marker of necrosis and severity in acute pancreatitis[J]. Pancreas, 2018, 47(6): 715-720.
[9]
Goswami P, Sonika U, Moka P, et al. Intestinal fatty acid binding protein and citrulline as markers of gut injury and prognosis in patients with acute pancreatitis[J]. Pancreas, 2017, 46(10): 1275-1280.
[10]
胡丽萍, 陈文虎, 朱翔宇, 等. 血清降钙素原在急性胰腺炎危重度早期评估中的价值研究[J]. 中华全科医学, 2017, 15(7): 1147-1149.
[11]
Portelli M, Jones CD. Severe acute pancreatitis: pathogenesis, diagnosis and surgical management[J]. Hepatobiliary Pancreat Dis Int, 2017, 16(2): 155-159.
[12]
Barbeiro DF, Koike MK, Coelho AM, et al. Intestinal barrier dysfunction and increased COX-2 gene expression in the gut of elderly rats with acute pancreatitis[J]. Pancreatology, 2016, 16(1): 52-56.
[1] 张秋彬, 张楠, 林清婷, 徐军, 朱华栋, 姜辉. 急性胰腺炎合并急性肾损伤患者的预后评估[J]. 中华危重症医学杂志(电子版), 2023, 16(05): 382-389.
[2] 黄翠君, 张喜玲, 刘思嘉, 刘云建. 重症急性胰腺炎营养支持治疗研究进展[J]. 中华普通外科学文献(电子版), 2023, 17(05): 385-390.
[3] 张海涛, 康婵娟, 翟静洁. 胰管支架置入治疗急性胆源性胰腺炎效果观察[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 654-657.
[4] 陈宇凡, 屈振南, 陈宝坤. 1684例无症状胆囊结石患者病情进展影响因素分析[J]. 中华普外科手术学杂志(电子版), 2023, 17(03): 311-314.
[5] 陈朔, 陈峰, 程飞, 项捷. 糖原累积病Ⅰ型并发胰腺炎肝移植术后胰腺梗死一例[J]. 中华移植杂志(电子版), 2023, 17(05): 300-302.
[6] 陈海艳, 周惠敏, 崔佳琪, 杨军. 经尿道膀胱镜钬激光碎石术后并发中度重症急性胰腺炎一例[J]. 中华肝脏外科手术学电子杂志, 2023, 12(04): 461-463.
[7] 许磊, 孙杰, 陈先志, 张家泉, 李旺勇, 冯其柱, 王琦. 血液净化治疗在高血脂性重症胰腺炎中的应用[J]. 中华肝脏外科手术学电子杂志, 2023, 12(04): 464-468.
[8] 王小红, 钱晶, 翁文俊, 周国雄, 朱顺星, 祁小鸣, 刘春, 王萍, 沈伟, 程睿智, 秦璟灏. 巯基丙酮酸硫基转移酶调控核因子κB信号介导自噬对重症急性胰腺炎大鼠的影响及机制[J]. 中华消化病与影像杂志(电子版), 2023, 13(06): 422-426.
[9] 陆萍, 邹健. 凝血和纤维蛋白溶解标志物的动态变化对急性胰腺炎患者预后的评估价值[J]. 中华消化病与影像杂志(电子版), 2023, 13(06): 427-432.
[10] 吉茜茜, 田尧, 马林, 钱进. 红细胞分布宽度-白蛋白比值联合BISAP评分对急性胰腺炎严重程度及死亡率的预测价值[J]. 中华消化病与影像杂志(电子版), 2023, 13(06): 433-438.
[11] 黄岩, 刘晓巍, 杨春玲, 兰烨. 急性胰腺炎合并糖尿病患者的临床特征及血糖代谢与病情严重度的相关性[J]. 中华消化病与影像杂志(电子版), 2023, 13(06): 439-442.
[12] 马强, 李军, 苟丽娟. 重症急性胰腺炎miR-21-3p、RUNX3表达水平及对病情发展程度的预测[J]. 中华消化病与影像杂志(电子版), 2023, 13(05): 337-341.
[13] 孙旻. 血液淀粉酶、C反应蛋白、降钙素原及乳酸脱氢酶在急性胰腺炎患者病情评价及预后预测中的价值[J]. 中华消化病与影像杂志(电子版), 2023, 13(05): 331-336.
[14] 王庆, 夏婷婷. 未成熟粒细胞计数、C反应蛋白、中性粒细胞/淋巴细胞、降钙素原结合MCTSI评分在急性胆源性胰腺炎中的诊断价值[J]. 中华消化病与影像杂志(电子版), 2023, 13(04): 224-228.
[15] 韩优, 郝婧, 董红霞, 戴丽, 周保硕, 高慧贤. 经鼻空肠营养管在急性重症胰腺炎的早期应用及护理方法分析[J]. 中华胃肠内镜电子杂志, 2023, 10(04): 274-277.
阅读次数
全文


摘要